Cargando…
Impact of facial angiofibromas in tuberous sclerosis complex and reported efficacy of available treatments
Tuberous Sclerosis Complex (TSC) is a genetic condition which leads to a loss of inhibition of cellular growth. Facial angiofibromas (FAs) are hamartomatous growths associated with TSC that appear as multiple small, erythematous papules on the skin of the face and may resemble more severe forms of a...
Autores principales: | Monaghan, Marie, Takhar, Pooja, Langlands, Luke, Knuf, Markus, Amin, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9467435/ https://www.ncbi.nlm.nih.gov/pubmed/36106321 http://dx.doi.org/10.3389/fmed.2022.967971 |
Ejemplares similares
-
Facial Angiofibromas and Periungual Fibromas in Tuberous Sclerosis
por: Tsujimoto, Hiraku, et al.
Publicado: (2017) -
Sirolimus Ointment for Facial Angiofibromas in Individuals with Tuberous Sclerosis Complex
por: Amin, S., et al.
Publicado: (2017) -
Topical rapamycin for facial angiofibromas in tuberous sclerosis complex
por: Safa, Gilles
Publicado: (2017) -
Isolated Unilateral Facial Angiofibroma or Segmental Tuberous Sclerosis Complex?
por: Supekar, Bhagyashree B., et al.
Publicado: (2021) -
Efficacy and Safety of Topical Timolol for the Treatment of Facial Angiofibroma in Children with Tuberous Sclerosis Complex
por: Ghazavi, Mohammadreza, et al.
Publicado: (2023)